Risk of progression following a negative biopsy in prostate cancer active surveillance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5608
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk of progression following a negative biopsy in prostate cancer active surveillance ; day:25 ; month:8 ; year:2022 ; pages:1-7
Prostate cancer and prostatic diseases ; (25.8.2022), 1-7
- Creator
-
Beckmann, Kerri
Santaolalla, Aida
Sugimoto, Mikio
Carroll, Peter
Rubio, Jose
Villers, Arnauld
Bjartell, Anders
Morgan, Todd
Dasgupta, Prokar
Hemelrijck, Mieke Van
Elhage, Oussama
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41391-022-00582-x
- URN
-
urn:nbn:de:101:1-2022111209062554400366
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beckmann, Kerri
- Santaolalla, Aida
- Sugimoto, Mikio
- Carroll, Peter
- Rubio, Jose
- Villers, Arnauld
- Bjartell, Anders
- Morgan, Todd
- Dasgupta, Prokar
- Hemelrijck, Mieke Van
- Elhage, Oussama
- SpringerLink (Online service)
Other Objects (12)
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Evaluation of Magnetic Resonance Imaging/ Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy
Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Evaluation of Magnetic Resonance Imaging/ Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy
Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
Biparametric MRI in prostate cancer during active surveillance: is it safe?
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
Evaluation of Magnetic Resonance Imaging/ Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy
Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance
Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study
Biparametric MRI in prostate cancer during active surveillance: is it safe?